# Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo

> **NCT03004924** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 753 (actual)

## Conditions studied

- Bacterial Conjunctivitis

## Interventions

- **DRUG:** SHP640
- **DRUG:** PVP-I 0.6%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03004924
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-29
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-10-01
- **Target enrollment:** 753 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03004924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03004924, "Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03004924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*